openPR Logo
Press release

MicroWorld’s eScan wins VB100% in Comparative Test

02-06-2008 08:02 PM CET | IT, New Media & Software

Press release from: MicroWorld Technologies

MicroWorld’s eScan Corporate adds another feather to its cap. The comprehensive security solution that combines AntiVirus, AntiSpam and Content Security in one product suite has won yet another VB100% in a Comparative Test conducted on Windows Server 2003.

eScan is one of the few products that has consistently achieved the widely respected VB100% over the last many years. In the February review the software showed excellent test results in malware categories like In the Wild, File Infector, Polymorphic, Worms & Bots, DOS and Macro. eScan managed this by using a combination of proactive and reactive technologies in identifying malicious code.

“It’s quite gratifying to know that eScan has been awarded VB100% in the comparative test. The Virus Bulletin test is regarded as an absolute benchmark in the Security Industry and this result stands testimony to the effectiveness of our technologies and accuracy of Virus detection. We also realize that the award puts the onus on us to continue to maintain and exceed the quality standards of our product,” said Govind Rammurthy, CEO of MicroWorld.

As a security product that protects computers and networks against a gamut of threats, eScan is powered by many innovative technologies. MicroWorld’s unique MWL technology enables eScan to intercept and block incoming threats at the transport layer of connectivity, thus placing it ahead of almost all other AntiVirus solutions which scan for files at the Application level.

The software uses advanced Behavioral Detection algorithms to block previously unknown threats and virus mutants, while it’s also empowered with technologies that repair changes made by Viruses in the system registry. Likewise, the Non Intrusive Learning Patterns used in eScan is a revolutionary method in Spam Fighting.

New version of eScan Corporate has some powerful features that give better control and more advanced means to the System Administrator to protect organizational networks. The management Console now provides options for installation, administration control, deployment of updates, upgrades, and license keys, enforcement of security policies, covering rogue machines and more. The newly added Application Control feature is used for controlling and blocking all unproductive and harmful programs in an organization’s network. The network monitoring tool TCP Connections now shows all active connections and established connections in the system.

eScan Corporate is fast becoming one of the most preferred security solutions among System Administrators across the world. The new VB100% awarded to eScan is another proof that the trust is not misplaced, viewed an independent Security Expert.

MicroWorld

Address:
Plot No 80, Road No 15, MIDC Marol Andheri (E), MUMBAI, INDIA

MicroWorld Technologies (www.mwti.net) is the developer of highly advanced AntiVirus, Content Security and Firewall software solutions eScan, MailScan, and eConceal. MicroWorld Winsock Layer (MWL) is the revolutionary technology that powers most of MicroWorld products enabling them to achieve several certifications and awards by some of the most prestigious testing bodies, notable among them being Virus Bulletin, Checkmark, TUCOWS, Red Hat Ready and Novell Ready.

For more information, please visit www.mwti.net

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MicroWorld’s eScan wins VB100% in Comparative Test here

News-ID: 36971 • Views:

More Releases from MicroWorld Technologies

MicroWorld Unveils eScan – Cyber Vaccine Edition
MicroWorld Technologies Inc., a pioneer in the field of cybersecurity, has launched eScan Version 22 - Cyber Vaccine Edition, a comprehensive cybersecurity solution aimed at empowering consumers, enterprises and governments across the world in their fight against digital malice. Equipped with cutting-edge technologies, MicroWorld's latest offering aims to reinvent cybersecurity in the face of an ever-evolving threat landscape, especially in light of the ongoing pandemic. The cyber vaccine edition is
Nemasis – VMS, armed with the Intelligence to Detect Proxylogon
In the wake of a ubiquitous cyber-attack being executed across the world, cybersecurity leader MicroWorld Technologies Inc., has announced their security solution Nemasis – Vulnerability Management System, being armed with intelligence to detect the highly catastrophic ProxyLogon Vulnerability. The on-premises versions of Microsoft Exchange Servers are being targeted in a pervasive global attack through multiple zero-day vulnerabilities that have recently been discovered. The vulnerability christened as ProxyLogon (CVE-2021-26855) allows the
MicroWorld Technologies to showcase futuristic cybersecurity solutions at GISEC …
With the aim of driving security transformation across the world, MicroWorld Technologies, a leading name from the cybersecurity sector, has confirmed their participation in the year’s biggest technology event – GISEC, which will be held at the Dubai World Trade Centre from the 6th to the 10th of December 2020. In a year which has displayed the malicious prowess that threat actors possess, MicroWorld plans to showcase their proactive cybersecurity

More Releases for Virus

Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects. Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817 The outbreak of Zika virus infection in Latin
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Oncolytic Virus 1.1 Outline of Oncolytic Virotherapy 1.2 Trail from Genesis to Biogenetics Primer of Virotherapy in Malignancies 2.1 Oncolytic Viruses towards Cancer 2.2 Approaches for Targeting Tumor Cells 2.2.1 Pro Apoptotic Targeting 2.2.2 Translational Targeting 2.2.3 Transcriptional Targeting 2.2.4 Transductional Targeting Mechanism